PubMed Health⌕ Search

Biomedical subjects

E Schinko

Publications and source records attributed to E Schinko.

3 recordsLinked to original sources

[Estrogens and bone metabolism].

The authors present a review referring to cellular and biochemical control systems of bone remodeling as well as the effect of estrogens on modulation of bone metabolism. Systemic and local control factors such as PTH, calcitonin, vitamin D, prostaglandins, insulin-like growth factor-1, transforming growth factor-beta are analyzed as possible indirect targets for the estrogen induced inhibition of bone resorption. A direct receptor-linked action of estrogens on the osteoblast-lining cell unit, the most important modulator or bone metabolism, is furtherwise examined. The precise mechanism of the beneficial effect of estrogens for the prevention of postmenopausal bone loss and the treatment of established osteoporosis has not yet been clearly identified, but it seems likely that multiple mechanisms may be involved since postmenopausal osteoporosis itself appears as a heterogenic clinical condition related to multiple pathogenetic factors.

Adult↗

Adenocarcinoma of the uterine cervix.

From 1970 to 1989, 39 patients with cervical adenocarcinoma (9.3% of all cervical cancers) were treated in the Department of Gynecology - University of Pavia. Adenocarcinoma seemed to be a disease epidemiologically different from epidermoid carcinoma. Treatment included radical hysterectomy, radiotherapy, radical hysterectomy and radiotherapy. In stage I disease survival was not significantly influenced by treatment modality. However in young patients without risk factors surgery seemed to obtain the best results; in high risk patients adjuvant radiotherapy did not apparently improve survival. Prognosis for adenocarcinoma seemed to be worse than for its squamous counterpart. The main prognostic factors were grading and lymph node status. Relapse occurred also a long time after treatment. In 2 cases we observed Cervical Intraepithelial Neoplasia grade 3 (CIN 3) in association with adenocarcinoma.

Adenocarcinoma↗

Diagnostic alternatives to second look in ovarian cancer.

The accuracy of the markers CA 125, CA 15-3, CA 50 serum levels and the CT findings as alternative monitoring techniques to second look has been evaluated in 25 patients. The negative predictive value for the CA 125 was of 55% and its sensibility seems not to be increased by the association of the other markers. For the CT findings we report a diagnostic accuracy of 76%.

Adult↗